Lipella pharmaceuticals launches innovative registry to advance oral lichen planus research

Pittsburgh, pa, august 22, 2024 – lipella pharmaceuticals, inc. (nasdaq: lipo) has launched an oral lichen planus (olp) patient registry. this online platform is designed to enhance research and drive the development of new treatments for olp, a chronic inflammatory disease affecting the mucous membranes of the mouth.
LIPO Ratings Summary
LIPO Quant Ranking